filo
- Amgen (AMGN) increased its revenue and profit guidance ranges for 2026 after releasing Q3 results that beat on both lines.
- Full-year revenue is now projected at $38.9B-$39.7B (consensus $38.97B), up from $38B-$39.4B prior. Non-GAAP EPS is seen at $22.90-$23.70 (consensus $23.02), compared to $22.30-$23.50 before.